Bio-Techne Corporation
TECH
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life sciā¦ read more
Healthcare
Biotechnology
37 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$57.92
Price-2.39%
-$1.41
1Y
Price
Market Cap
$9.061b
Mid
Price/Earnings 3y Avg5y Avg
109.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+7.1%
EBITDA Margin+12.9%
Net Profit Margin+25.9%
Free Cash Flow Margin+7.1%
EBITDA Margin+12.9%
Net Profit Margin+25.9%
Free Cash Flow MarginRevenue
$1.216b
-0.3%
1y CAGR+2.3%
3y CAGR+2.4%
5y CAGREarnings
$81.104m
+10.5%
1y CAGR-29.0%
3y CAGR-20.5%
5y CAGREPS
$0.52
+13.0%
1y CAGR-27.8%
3y CAGR-19.4%
5y CAGRBook Value
$2.034b
$2.523b
Assets$488.632m
Liabilities$337.185m
DebtDebt to Assets
13.4%
1.9x
Debt to EBITDAFree Cash Flow
$223.020m
-13.1%
1y CAGR+1.6%
3y CAGR-4.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company